You have until December 7 each year to change Medicare Advantage or Part D coverage for January 1; after that, the worst-case result is being locked into a plan that no longer fits your doctors, prescriptions, or out-of-pocket risk for the entire next year.

The recent legal change is the Inflation Reduction Act. For 2025, Medicare Part D adds a $2,000 annual out-of-pocket cap on covered prescription drugs and ends the old catastrophic cost-sharing structure. That makes drug costs more predictable, but it does not mean every plan is now equivalent.

If your main concern is prescription cost, switching can be smarter when your current plan has a weak formulary, high pharmacy cost-sharing, or excludes a drug you use. The new cap helps only after you spend enough on covered drugs in-network and under the plan's rules. A drug placed on a higher tier, subject to prior authorization, or omitted from the formulary can still create major problems.

Keeping your current Medicare Advantage plan often goes better when:

• your doctors and hospital stay in network
• your prescriptions remain on the plan's 2025 formulary
• the plan's maximum out-of-pocket limit for medical care is acceptable
• extra benefits matter more than provider flexibility

Switching goes better when you need broader provider choice or your drug list changed. Original Medicare + a standalone Part D plan can offer wider doctor access, but a Medigap policy may cost more and, in many states, can require medical underwriting if you are outside a guaranteed-issue window.

The legal decision point is not "Advantage versus traditional Medicare" in the abstract. It is whether the 2025 Annual Notice of Change shows worse networks, higher drug restrictions, or higher total expected costs despite the new Part D cap.